Yes, noted. But even w 4 bil OS if that happens in the months to come......well then at .60 cents that would equal $2.4 Billion market cap of what enzc did.
But they are diff companies, im seeing alot here......could go higher......or lower.......but as James Dean used to say: ‘Any either other way’, three cents is dirt cheap with all the massive dd and new events here now and years of research and Patents.......where we are at now, will i think be looked at as extremely cheap this summer.
For me, until we hit a market cap of at least $500 mil, im none too worried, $500 mil MC which is standard fare for sooooo many biotech Naz stocks with nomproduct out and may never have one.....in pre-Phase or Phase I, havent made a dollar, have $20 mil in debt...yet their stocks trade over a dollar because of Potential. Biotech Potential......and with the huge licensing deal last week, the new Patent granted last month, and alll the other DD we are seeing......as some have been saying RGBP has more going for it then many Naz biotechs, right now.....and pps is below .03. i like the upside here, its rather staggering.
News 
Market Data 
Discover 
